Oil prices surged about 3% following US military strikes on Iranian vessels accused of laying mines in the Strait of Hormuz, with Brent crude hitting $97.07 a barrel. Despite heightened tensions, US stocks rose as investors remained hopeful about peace negotiations between the US and Iran, with both sides reporting positive talks. However, concerns persist over sustained high oil prices due to ongoing Middle East conflicts, which could impact inflation and Federal Reserve interest rate decisions. The market remains cautious as geopolitical risks continue to affect global energy supply.
BrainStorm Cell Therapeutics has appointed Peter J. Pitts, a former FDA Associate Commissioner, to its Board of Directors as the company prepares to start its Phase 3b ENDURANCE trial for its ALS therapy NurOwn. This trial is notable for being the fi...
FirstService Corporation's subsidiary, Century Fire Protection, has acquired GSC Fire & Security and Titan Fire Protection, enhancing its scale and service capabilities in the U.S. Sun Belt region. GSC operates in Texas providing fire alarm and sprin...
Marvell Technology reported adjusted earnings of 80 cents per share, slightly above analyst estimates, with revenue rising 28% year-over-year to $2.42 billion. The company's data center segment, driven by AI infrastructure demand, hit a record $1.83 ...
Wall Street's recent rally is heavily reliant on a small group of mega-cap technology stocks like Nvidia, Apple, and Alphabet, driven by strong demand for AI-related products and investments. Analysts warn that this narrow market breadth, combined wi...
Trogenix has dosed the first patient in its Phase I/II ADePT trial testing TGX-007, a dual-payload gene therapy for glioblastoma, at sites in the UK and US. TGX-007 uses a proprietary Synthetic Super-Enhancer platform to selectively kill tumor cells ...
